Modeling Ebola Virus Transmission Using Ferrets

Our knowledge regarding transmission of EBOV between individuals is vague and is mostly limited to spreading via direct contact with infectious bodily fluids. Studying transmission parameters such as dose and route of infection is nearly impossible in naturally acquired cases—hence the requirement for a laboratory animal model. Here, we show as a proof of concept that ferrets can be used to study EBOV transmission. We also show that transmission in the absence of direct contact is frequent, as all animals with indirect contact with the infected ferrets had detectable antibodies to the virus, and one succumbed to infection. Our report provides a new small-animal model for studying EBOV transmission that does not require adaptation of the virus, providing insight into virus transmission among humans during epidemics. ABSTRACT Ebola virus (EBOV) has been responsible for sporadic outbreaks in Central Africa since 1976 and has the potential of causing social disruption and public panic as illustrated by the 2013–2016 epidemic in West Africa. Transmission of EBOV has been described to occur via contact with infected bodily fluids, supported by data indicating that infectious EBOV could be cultured from blood, semen, saliva, urine, and breast milk. Parameters influencing transmission of EBOV are, however, largely undefined in part due to the lack of an established animal model to study mechanisms of pathogen spread. Here, we investigated EBOV transmissibility in male and female ferrets. After intranasal challenge, an infected animal was placed in direct contact with a naive ferret and in contact with another naive ferret (separated from the infected animal by a metal mesh) that served as the indirect-contact animal. All challenged animals, male direct contacts, and one male indirect contact developed disease and died. The remaining animals were not viremic and remained asymptomatic but developed EBOV-glycoprotein IgM and/or IgG specific antibodies—indicative of virus transmission. EBOV transmission via indirect contact was frequently observed in this model but resulted in less-severe disease compared to direct contact. Interestingly, these observations are consistent with the detection of specific antibodies in humans living in areas of EBOV endemicity. IMPORTANCE Our knowledge regarding transmission of EBOV between individuals is vague and is mostly limited to spreading via direct contact with infectious bodily fluids. Studying transmission parameters such as dose and route of infection is nearly impossible in naturally acquired cases—hence the requirement for a laboratory animal model. Here, we show as a proof of concept that ferrets can be used to study EBOV transmission. We also show that transmission in the absence of direct contact is frequent, as all animals with indirect contact with the infected ferrets had detectable antibodies to the virus, and one succumbed to infection. Our report provides a new small-animal model for studying EBOV transmission that does not require adaptation of the virus, providing insight into virus transmission among humans during epidemics.

[1]  X. Qiu,et al.  The Makona Variant of Ebola Virus Is Highly Lethal to Immunocompromised Mice and Immunocompetent Ferrets. , 2018, The Journal of infectious diseases.

[2]  S. Yaya,et al.  The perspective of gender on the Ebola virus using a risk management and population health framework: a scoping review , 2017, Infectious Diseases of Poverty.

[3]  J. Dye,et al.  Identification and pathological characterization of persistent asymptomatic Ebola virus infection in rhesus monkeys , 2017, Nature Microbiology.

[4]  X. Qiu,et al.  Characterization of Sudan Ebolavirus infection in ferrets , 2017, Oncotarget.

[5]  J. Glynn,et al.  A systematic review and meta-analysis of seroprevalence surveys of ebolavirus infection , 2017, Scientific Data.

[6]  D. Bausch,et al.  Ebola Virus Shedding and Transmission: Review of Current Evidence. , 2016, The Journal of infectious diseases.

[7]  G. Gao,et al.  Pathogenicity Comparison Between the Kikwit and Makona Ebola Virus Variants in Rhesus Macaques. , 2016, The Journal of infectious diseases.

[8]  C. Mire,et al.  Oral and Conjunctival Exposure of Nonhuman Primates to Low Doses of Ebola Makona Virus , 2016, The Journal of infectious diseases.

[9]  X. Qiu,et al.  Ferrets Infected with Bundibugyo Virus or Ebola Virus Recapitulate Important Aspects of Human Filovirus Disease , 2016, Journal of Virology.

[10]  C. Mire,et al.  The Domestic Ferret (Mustela putorius furo) as a Lethal Infection Model for 3 Species of Ebolavirus , 2016, The Journal of infectious diseases.

[11]  S. Günther,et al.  Delayed Disease Progression in Cynomolgus Macaques Infected with Ebola Virus Makona Strain , 2015, Emerging infectious diseases.

[12]  S. Nichol,et al.  Utility of Oral Swab Sampling for Ebola Virus Detection in Guinea Pig Model , 2015, Emerging infectious diseases.

[13]  Joseph B. Prescott,et al.  Shedding of Ebola Virus in an Asymptomatic Pregnant Woman. , 2015, The New England journal of medicine.

[14]  Stephan Günther,et al.  Emergence of Zaire Ebola virus disease in Guinea. , 2014, The New England journal of medicine.

[15]  J. Strong,et al.  Evaluation of transmission risks associated with in vivo replication of several high containment pathogens in a biosafety level 4 laboratory , 2014, Scientific Reports.

[16]  X. Qiu,et al.  Ebola Virus Transmission in Guinea Pigs , 2014, Journal of Virology.

[17]  G. Kobinger,et al.  Transmission of Ebola virus from pigs to non-human primates , 2012, Scientific Reports.

[18]  N. Wauquier,et al.  Risk factors for Zaire ebolavirus--specific IgG in rural Gabonese populations. , 2011, The Journal of infectious diseases.

[19]  G. Kobinger,et al.  Replication, pathogenicity, shedding, and transmission of Zaire ebolavirus in pigs. , 2011, The Journal of infectious diseases.

[20]  N. Wauquier,et al.  Correction: High Prevalence of Both Humoral and Cellular Immunity to Zaire ebolavirus among Rural Populations in Gabon , 2010, PLoS ONE.

[21]  N. Wauquier,et al.  High Prevalence of Both Humoral and Cellular Immunity to Zaire ebolavirus among Rural Populations in Gabon , 2010, PloS one.

[22]  S. Dowell,et al.  Assessment of the risk of Ebola virus transmission from bodily fluids and fomites. , 2007, The Journal of infectious diseases.

[23]  G. Neumann,et al.  Molecular Determinants of Ebola Virus Virulence in Mice , 2006, PLoS pathogens.

[24]  P. Debré,et al.  Early immune responses accompanying human asymptomatic Ebola infections , 2001, Clinical and experimental immunology.

[25]  P. Debré,et al.  Human asymptomatic Ebola infection and strong inflammatory response , 2000, The Lancet.

[26]  H. Feldmann,et al.  Prevalence of IgG antibodies to Ebola virus in individuals during an Ebola outbreak, Democratic Republic of the Congo, 1995. , 1999, The Journal of infectious diseases.

[27]  K. Steele,et al.  Transmission of Ebola virus (Zaire strain) to uninfected control monkeys in a biocontainment laboratory , 1995, The Lancet.